ORGNW (Origin Materials, Inc. Warrants)
Insider Trading Activity
Every open-market purchase and sale reported by ORGNW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-13 | John Bissell | CEO and Director | A | — | — |
| 2026-04-13 | Joshua C. Lee | GC, Chief Compliance Officer | A | — | — |
| 2026-04-13 | Matthew T Plavan | CFO and COO | A | — | — |
| 2026-03-05 | Joshua C. Lee | GC, Chief Compliance Officer | A | — | — |
| 2026-03-05 | John Bissell | CEO and Director | A | — | — |
| 2026-03-05 | Matthew T Plavan | CFO and COO | A | — | — |
| 2026-01-20 | Matthew T Plavan | CFO and COO | Sell | — | — |
| 2026-01-05 | John Hickox | Director | A | — | — |
| 2026-01-05 | CRAIG A ROGERSON | Director | A | — | — |
| 2026-01-05 | R Tony Tripeny | Director | A | — | — |
| 2025-12-29 | Joshua C. Lee | General Counsel | Sell | — | — |
| 2025-12-29 | John Bissell | CEO and Director | Sell | — | — |
| 2025-12-29 | Matthew T Plavan | CFO and COO | Sell | — | — |
| 2025-12-19 | John Bissell | CEO and Director | Sell | — | — |
| 2025-12-17 | Joshua C. Lee | General Counsel | Sell | — | — |
| 2025-11-20 | John Bissell | CEO and Director | G | — | — |
| 2025-11-04 | Matthew T Plavan | CFO and COO | Sell | — | — |
| 2025-10-01 | CRAIG A ROGERSON | Director | A | — | — |
| 2025-10-01 | R Tony Tripeny | Director | A | — | — |
| 2025-10-01 | John Hickox | Director | A | — | — |
| 2025-08-21 | Joshua C. Lee | General Counsel | Sell | — | — |
| 2025-07-02 | CRAIG A ROGERSON | Director | A | — | — |
| 2025-07-02 | R Tony Tripeny | Director | A | — | — |
| 2025-07-02 | John Hickox | Director | A | — | — |
| 2025-06-13 | John Bissell | CEO and Director | M | — | — |
| 2025-05-08 | Kathleen B Fish | Director | A | — | — |
| 2025-05-08 | John Hickox | Director | A | — | — |
| 2025-05-08 | James C. Stephanou | Director | A | — | — |
| 2025-05-08 | William J. Harvey | Director | A | — | — |
| 2025-05-08 | CRAIG A ROGERSON | Director | A | — | — |
| 2025-05-08 | R Tony Tripeny | Director | A | — | — |
| 2025-04-02 | John Hickox | Director | A | — | — |
| 2025-04-02 | R Tony Tripeny | Director | A | — | — |
| 2025-04-02 | CRAIG A ROGERSON | Director | A | — | — |
| 2025-03-07 | Joshua C. Lee | General Counsel | Sell | — | — |
| 2025-03-07 | Matthew T Plavan | CFO and COO | Sell | — | — |
| 2025-03-07 | John Bissell | CEO and Director | Sell | — | — |
| 2025-02-28 | John Bissell | CEO and Director | A | — | — |
| 2025-02-28 | Matthew T Plavan | CFO and COO | A | — | — |
| 2025-02-28 | Joshua C. Lee | General Counsel | A | — | — |
| 2025-01-06 | Joshua C. Lee | General Counsel | Sell | — | — |
| 2025-01-03 | CRAIG A ROGERSON | Director | A | — | — |
| 2025-01-03 | John Hickox | Director | A | — | — |
| 2025-01-03 | R Tony Tripeny | Director | A | — | — |
| 2024-12-31 | John Bissell | CEO and Director | MIXED | — | — |
| 2024-12-31 | Joshua C. Lee | General Counsel | MIXED | — | — |
| 2024-12-31 | Matthew T Plavan | CFO and COO | MIXED | — | — |
| 2024-12-17 | John Bissell | Co-CEO and Director | Sell | — | — |
| 2024-12-17 | Joshua C. Lee | General Counsel | Sell | — | — |
| 2024-11-21 | Richard J. Riley | CO-CEO AND DIRECTOR | Buy | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 9,758,911 | — |
| — | Director | 5,869,811 | — |
| — | CO-CEO AND DIRECTOR | 2,025,902 | — |
| — | CEO and Director | 2,007,973 | — |
| — | CFO and COO | 1,340,231 | — |
| — | Director | 874,879 | — |
| — | Director | 776,570 | — |
| — | Chief Commercial Officer | 732,654 | — |
| — | Director | 722,260 | — |
| — | GC, Chief Compliance Officer | 636,884 | — |
| — | Director | 560,942 | — |
| — | Director | 451,076 | — |
| — | Chief Financial Officer | 381,330 | — |
| — | Director | 352,827 | — |
| — | Director | 343,576 | — |
| — | Director | 172,986 | — |
| — | Interim CFO | 136,650 | — |
| — | Director | 118,558 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ORGNW quote page; the site-wide leaderboard is on the insider transactions hub.